Article Text

Download PDFPDF
Sequential Trial of Effect of Phenobarbitone on Serum Bilirubin of Preterm Infants
  1. F. Carswell,
  2. M. M. Kerr,
  3. I. R. Dunsmore


    (1) Phenobarbitone in a dose of 8 mg/kg per day was given in twice-daily intramuscular doses to preterm infants with a gestational age of 36 completed weeks or less. The phenobarbitone was started within the first 24 hours after birth. (2) The peak serum bilirubin levels of these infants and matched, randomly selected, control infants were compared sequentially. A significantly lower (P [unk]0·05) peak bilirubin level was found in the treated group. (3) This lower level of serum bilirubin may be less liable to produce neurological damage in preterm infants.

    Statistics from

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.